Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review

Duran Josefina; Bockorny Margarita; Dalal Deepan; LaValley Michael; Felson David T.

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review

【24h】

Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review

机译：甲氨蝶呤剂量是类风湿关节炎生物学试验中偏倚的来源：系统评价

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives To evaluate if optimal dose of either oral or injectable regimens of methotrexate (MTX) of 25mg/week was used in the comparator arms of studies comparing biologic drugs with MTX in rheumatoid arthritis (RA).

机译：目的为了评估在风湿性关节炎（RA）中将生物药物与MTX进行比较的研究的比较组中，是否使用25mg /周的甲氨蝶呤（MTX）口服或注射方案的最佳剂量。

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2016年第9期|共4页
作者
Duran Josefina; Bockorny Margarita; Dalal Deepan; LaValley Michael; Felson David T.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
DMARDs (biologic); Methotrexate; Rheumatoid Arthritis;

机译：DMARDs（biologic）;甲氨蝶呤;类风湿关节炎;
入库时间 2022-08-18 10:16:36

相似文献

外文文献
中文文献
专利

1. Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review [J] . Duran Josefina, Bockorny Margarita, Dalal Deepan, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2016,第9期

机译：甲氨蝶呤剂量是类风湿关节炎生物学试验中偏倚的来源：系统评价
2. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. [J] . Fleischmann RM, Cohen SB, Moreland LW, Current medical research and opinion . 2005,第8期

机译：开始使用英夫利昔单抗治疗的类风湿关节炎患者的甲氨蝶呤剂量减少：英夫利昔单抗类风湿关节炎甲氨蝶呤渐缩（iRAMT）试验。
3. Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A?Systematic Review [J] . Choi May Y., Barnabe Cheryl, Barber Claire E., Arthritis care & research . 2019,第5期

机译：类风湿性关节炎中甲氨蝶呤的随机对照试验的务实论甲氨蝶呤：a？系统评价
4. Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata [C] . Yuanyuan Feng, Janeja Vandana P., Yesha Yelena, IEEE International Conference on Computational Advances in Bio and Medical Sciences . 2015

机译：海报：对类风湿关节炎的主要结局进行分类：从临床试验元数据中发现知识
5. Models and outcomes of team care for the management of rheumatoid arthritis across different countries: A systematic review. [D] . Chhabra, Monika. 2009

机译：跨国治疗类风湿关节炎的团队护理模型和结果：系统评价。
6. Methotrexate dosage as a source of bias in biologic trials in Rheumatoid Arthritis: a Systematic Review [O] . Josefina Durán, Margarita Bockorny, Deepan Dalal, -1

机译：甲氨蝶呤剂量是类风湿关节炎生物学试验中偏见的来源：系统评价
7. Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review [O] . Durán, Josefina, Bockorny, Margarita, Dalal, Deepan, 2016

机译：甲氨喋呤剂量作为类风湿性关节炎生物学试验偏倚的来源：系统评价

Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review

摘要

著录项

相似文献

相关主题

期刊订阅